Back to search

Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.

Data up to Jan 2025

Published1997
Citations63
References32

Total Citations Per Year

Abstract

References (32)

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

1993 • 2,884 citations

Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer

1994 • 2,071 citations

Mutation of a mutL Homolog in Hereditary Colon Cancer

1994 • 1,834 citations

Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer

1994 • 1,544 citations

Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer

1995 • 785 citations

Isolation of a transforming sequence from a human bladder carcinoma cell line

1982 • 776 citations

Cancer risk associated with germline DNA mismatch repair gene mutations

1997 • 693 citations

The role of DNA mismatch repair in platinum drug resistance.

1996 • 607 citations

Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis

1995 • 536 citations

GTBP, a 160-Kilodalton Protein Essential for Mismatch-binding Activity in Human Cells

1995 • 528 citations

Loss of DNA mismatch repair in acquired resistance to cisplatin.

1996 • 505 citations

On the nature of hereditable variation in cultured somatic cells

1976 • 497 citations

Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation

1994 • 496 citations

Mutations of GTBP in Genetically Unstable Cells

1995 • 471 citations

An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.

1993 • 445 citations

Mutator phenotypes in human colorectal carcinoma cell lines.

1994 • 428 citations

Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.

1996 • 422 citations

MSH2 deficient mice are viable and susceptible to lymphoid tumours

1995 • 378 citations

Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance.

1995 • 351 citations

APC mutations in colorectal tumors with mismatch repair deficiency.

1996 • 329 citations

Comparison of the in vitro transforming activities of human papillomavirus types.

1988 • 303 citations

Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines.

1995 • 301 citations

Transcription-Coupled Repair Deficiency and Mutations in Human Mismatch Repair Genes

1996 • 289 citations

The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin

1996 • 198 citations

Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair

1996 • 181 citations

Binding of Mismatched Microsatellite DNA Sequences by the Human MSH2 Protein

1994 • 166 citations

Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.

1996 • 165 citations

Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.

1988 • 157 citations

Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles.

1990 • 115 citations

Differential cellular expression of the human MSH2 repair enzyme in small and large intestine.

1995 • 64 citations

Loss of Heterozygosity and Base Substitution at the APRT Locus in Mismatch-Repair-Proficient and -Deficient Colorectal Carcinoma Cell Lines

1996 • 32 citations

Cloning and expression of the Xenopus and mouse Msh2 DNA mismatch repair genes

1994 • 25 citations

Cited By (0)

No citing papers found in database

Mutator phenotype in Msh2-deficient murine embryonic fibroblasts. (1997) – PubMed | Metascience Observatory Explorer